AstraZeneca: A Defensive Anchor with a Strong Product Portfolio
Healthcare stocks have historically been among the highest-yielding sectors despite setbacks.
With its move to the New York Stock Exchange, AstraZeneca increases its visibility and global impact.
Reading Time: 2 minutes
Despite the recent weak performance in the healthcare sector, AstraZeneca (LSE: AZN) remains an exciting stock for long-term oriented investors. The pharmaceutical industry is considered a classic defensive sector that provides stability to portfolios, particularly during times of crisis. Along with consumer staples, it is one of the highest-yielding sectors over the past 100 years - a quality that proves valuable in times of economic uncertainty. For those looking to make their portfolio more resilient, AstraZeneca is a solid candidate. The company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
